BETTER THAN THE INDUSTRY. ALWAYS ONE STEP AHEAD.
By unifying over 75 million structured data points from 250+ global sources, QYOBO reveals hidden patterns that your competition can’t see. Continuously updated and built to provide tailored insights relevant to your company, it delivers unique intelligence that nobody else can. We cut through the noise and transform raw data into competitive advantage.
Vision
QYOBO is the engine that transforms big data into smarter actions. Pharma data is vast, scattered, and complex. We connect the dots, turning fragmented information into insightful actions that reduce costs, mitigate risks, and seize market opportunities with confidence.
QYOBO was founded in Munich with the goal of replacing outdated, fragmented data practices in the pharmaceutical industry with a smarter, data-driven approach. After winning BASF’s global startup challenge, the platform gained recognition through awards such as WECONOMY, Science4Life, the EXIST business startup grant, BMWi “digital innovations” award and the CPHI Pharma Award 2024. From its early days at the WERK1 incubator, QYOBO has expanded its platform to cover entire supply chains and manufacturing sites, introducing innovations such as the first AI-based price forecast. QYOBO has grown every year since then and serves clients such as Santos, Novartis, BASF, Biocon, Grünenthal, and Aspen Pharmacare.
QYOBO won the Global CPHI Award for Supply Chain Excellence at the CPHI Pharma Awards in Milan in 2024 for our QYOBO platform, which provides global supply chain data and risk management tools for pharmaceutical companies.
values
THE QYOBO VALUES.
We pride ourselves on the quality of our software, our laser-sharp focus on improving it each day, and the collaborative environment we have created for anyone working at QYOBO.
Each of us has the freedom to organize our work and shape our outcomes in our own way. When I deliver a result, it bears my name and reflects the quality of my work.
At QYOBO, quality is not just about the products we create; it defines every aspect of how we operate. From groundbreaking technology to innovative sales strategies and impactful marketing, we aim to set the highest standards. Our commitment is to consistently deliver exceptional results and are pragmatic in how we get there. We always support each other, but also keep challenging how we do things to help each of us achieve the next level.
We communicate directly, and don’t dance around the bush. Trust and honesty are the very foundation of how we operate.
Whatever we do, it does not matter who proposes an idea, it only matters what creates the best result for our QYOBO as a product and company. We share an “obligation to dissent”, meaning that if someone does not agree that we’re pursuing the best approach or solution, they are obliged to speak up.
BRING YOUR CAREER TO THE NEXT LEVEL WITH US
You like a challenge and have an ambition to be part of something big? So do we. Explore our open jobs positions and revolutionize the pharma market with us.
Dr. Markus Felgenhauer
Chief Executive Officer
Markus graduated in Physics from Technical University of Munich (TUM) in 2012. He then pursued a PhD at BMW– supervised by the TUM and Stanford University. After his studies, Markus joined the consulting firm McKinsey & Company in 2016 exploring different industries, before specializing in the pharmaceutical sector. Markus is in charge of strategy, sales and marketing and product innovation.
Dr. Eric Parzinger
Chief Technology Officer
Eric graduated in Physics alongside Markus in 2012 at TUM. By that time, he had already spent half his life writing software. He pursued his PhD at the Center for Nanotechnology and Nanomaterials of the Walter Schottky Institute at TUM and the University of California, Berkeley. Eric oversees the QYOBO platform’s technical operations, ensuring seamless functionality across backend, data transformations, integrity checks, and frontend.
Julian Ruß
Chief Data Officer
Julian earned an MSc in Electrical Engineering and Information Technology at TUM in 2023, with a thesis on machine learning applications. After completing his BSc at TUM, he co-founded QYOBO. His early interest in software engineering, particularly cybersecurity and data analytics, was enhanced by extensive experience at Simovative. Julian oversees the collection, harmonization and integration of data from 250+ global data sources.
Insights
19 August 2025
15% U.S. Tariffs on EU Pharmaceuticals: Ireland’s Manufacturing Hub in Focus
14 May 2025
How Tariff Uncertainty Is Reshaping U.S. Pharma Supply Chains
